The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
Alan B. Cohen,
In this issue of the Quarterly, readers will find an eclectic mix of articles that cut across all four principal areas of the Journal’s editorial… More
Will Boles, Ruth Kennedy, Emma Siewert, Diane Rowland, Barbara Lyons, Rebekah E. Gee,
Twelve states have not yet expanded Medicaid under the Affordable Care Act. In a new Perspective, Will Boles of Louisiana State University Health Sciences Center School of Medicine, along with Ruth Kennedy, Emma Siewert, Diane Rowland, Barbara Lyons, and Rebekah E. Gee, suggest that Louisiana can serve as a model for new Medicaid expansion states seeking to rapidly enroll people within a limited administrative budget. More
David S. Curtis, Thomas E. Fuller-Rowell, Daniel L. Carlson, Ming Wen, Michael R. Kramer,
Low birth weight and infant mortality rates vary among place and racial group in the United States, with economic resources being a likely fundamental contributor to these disparities. The goals of this study were to examine time-varying county median income as a predictor of LBW rates and Black-White LBW disparities and to test county prevalence and racial disparities in maternal sociodemographic and health risk factors as mediators. More
Maria-Elena De Trinidad Young, Hannah Sarnoff, Dana Lang, A. Susana Ramírez,
Although immigration policy is recognized as a social determinant of health, less is known about how mechanisms, such as news coverage of policy, influence intermediary and proximal health processes like seeking health care. More
David H. Rehkopf, Frank F. Furstenberg, Holly Elser, Christian Jackson, Nicole Levy, John W. Rowe, The Aging Society Research Network,
Context: Although it is recognized that aspects of US state environments impact the likelihood that older adults age successfully, there is currently… More
Michael D. Rozier, Kavita Patel, Dori A. Cross,
Context: Health care delivery is now inextricably linked to the use of electronic health records (EHRs), which exert considerable influence over… More
Rowan G. M. Smeets, Dorijn F. L. Hertroijs, Ferdinand C. Mukumbang, Mariëlle E. A. L. Kroese, Dirk Ruwaard, Arianne M. J. Elissen,
Context: The complexity of integrated care and the need for transferable evaluation insights ask for a suitable evaluation paradigm. Realist… More
Aditi P. Sen, Yashaswini Singh, Mark K. Meiselbach, Matthew D. Eisenberg, Gerard F. Anderson,
Context: State and federal policymakers considering introduction of a health insurance “public option” can learn from Washington State, which… More
Jessica L. Webster, David Paul, Jonathan Purtle, Robert Locke, Neal D. Goldstein,
Context: Rates of preterm birth and infant mortality are alarmingly high in the United States. Legislated efforts may directly or indirectly reduce… More
Rachel Hogg-Graham, Elizabeth Graves, Glen P. Mays,
Context: While the novel coronavirus pandemic has underscored the important role of public health systems in protecting community health, it has also… More
Lindor Qunaj, Anna Kaltenboeck, Peter B. Bach,
This study by Lindor Qunaj of Montefiore Medical Center and colleagues finds that compulsory licensing, a practice whereby national authorities can enable the production of a generic before the original patent expires, is rarely used to address drug prices and, when used, is unlikely to contribute to price discounts. More
Previous issue
December 2021
Next issue
June 2022